Oscar Health, Inc. Announces 2024 Annual Meeting of Stockholders

Ticker: OSCR · Form: DEF 14A · Filed: Apr 25, 2024 · CIK: 1568651

Sentiment: neutral

Topics: Oscar Health, OSCR, DEF 14A, Annual Meeting, Proxy Statement

TL;DR

<b>Oscar Health, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, urging shareholders to vote.</b>

AI Summary

Oscar Health, Inc. (OSCR) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Oscar Health, Inc. will hold its 2024 Annual Meeting of Stockholders on June 6, 2024, at 10:00 a.m. Eastern time. The meeting will be conducted entirely virtually via live webcast. Stockholders are urged to vote their shares promptly by phone, internet, or mail. Instructions for attending the virtual meeting and voting are available in the proxy statement and notice of internet availability. Mark T. Bertolini, CEO and Director, signed the proxy statement dated April 25, 2024.

Why It Matters

For investors and stakeholders tracking Oscar Health, Inc., this filing contains several important signals. This filing is a Definitive Proxy Statement (DEF 14A), indicating it contains important information for shareholders regarding the upcoming annual meeting and voting procedures. The virtual format of the meeting suggests a move towards digital engagement, potentially increasing accessibility for a wider range of stockholders.

Risk Assessment

Risk Level: low — Oscar Health, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.

Analyst Insight

Review the proxy statement for details on voting procedures and any proposals to be discussed at the annual meeting.

Key Numbers

Key Players & Entities

FAQ

When did Oscar Health, Inc. file this DEF 14A?

Oscar Health, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 25, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Oscar Health, Inc. (OSCR).

Where can I read the original DEF 14A filing from Oscar Health, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Oscar Health, Inc..

What are the key takeaways from Oscar Health, Inc.'s DEF 14A?

Oscar Health, Inc. filed this DEF 14A on April 25, 2024. Key takeaways: Oscar Health, Inc. will hold its 2024 Annual Meeting of Stockholders on June 6, 2024, at 10:00 a.m. Eastern time.. The meeting will be conducted entirely virtually via live webcast.. Stockholders are urged to vote their shares promptly by phone, internet, or mail..

Is Oscar Health, Inc. a risky investment based on this filing?

Based on this DEF 14A, Oscar Health, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would indicate high risk.

What should investors do after reading Oscar Health, Inc.'s DEF 14A?

Review the proxy statement for details on voting procedures and any proposals to be discussed at the annual meeting. The overall sentiment from this filing is neutral.

How does Oscar Health, Inc. compare to its industry peers?

Oscar Health operates in the health insurance sector, providing health insurance plans.

Are there regulatory concerns for Oscar Health, Inc.?

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

Industry Context

Oscar Health operates in the health insurance sector, providing health insurance plans.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

What Investors Should Do

  1. Review the proxy statement for details on proposals and director nominations.
  2. Ensure your shares are voted by the deadline, following the provided instructions.
  3. Familiarize yourself with the virtual meeting access procedures.

Key Dates

Year-Over-Year Comparison

This is a DEF 14A filing for the 2024 Annual Meeting, following previous filings related to the company's operations and financial reporting.

Filing Stats: 4,841 words · 19 min read · ~16 pages · Grade level 12.3 · Accepted 2024-04-25 08:12:23

Key Financial Figures

Filing Documents

Executive Compensation Objectives and Philosophy

Executive Compensation Objectives and Philosophy 36 Determination of Executive Compensation 36 Elements of Compensation 38 Other Policies and Considerations 43 TABLE OF CONTENTS Compensation Committee Report 45

Executive Compensation Tables

Executive Compensation Tables 46 Summary Compensation Table 46 Grants of Plan-Based Awards in Fiscal 2023 47 Summary of Executive Compensation Arrangements 48 Outstanding Equity Awards at Fiscal Year-End Table 50 Option Exercises and Stock Vested in Fiscal 2023 52 Potential Payments Upon Termination or Change in Control 52 CEO Pay Ratio 57 Pay Versus Performance 58 2023 Director Compensation 62 Compensation Risk Assessment 65 Equity Compensation Plan Information 66

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 70 Certain Relationships and Related Person Transactions 73 Policies and Procedures for Related Person Transactions 73 +O Transaction with Sanford Health 73 Issuance and Sale of 7.25% Convertible Senior Notes due 2031 73 Amended and Restated Investors' Rights Agreement 74 Alphabet Agreements 74 Director and Officer Indemnification and Insurance 74 Stockholders' Proposals 75 Other Matters 76 Solicitation of Proxies 76 Oscar's Annual Report on Form 10-K 77 TABLE OF CONTENTS OSCAR HEALTH, INC. 75 Varick Street, 5 th Floor New York, New York 10013 Proxy Statement IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON THURSDAY, JUNE 6, 2024 This proxy statement and the 2023 Annual Report are available at http://www.proxyvote.com This proxy statement is furnished in connection with the solicitation by the Board of Directors of Oscar Health, Inc. of proxies to be voted at our Annual Meeting of Stockholders to be held on Thursday, June 6, 2024 (the "Annual Meeting"), at 10:00 a.m. Eastern time, and at any continuation, postponement, or adjournment of the Annual Meeting. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/OSCR2024 and entering your 16-digit control number included in your Notice of Internet Availability of Proxy Materials, on your proxy card or on the instructions that accompanied your proxy materials. Holders of record of shares of our Class A common stock, $0.00001 par value per share (the "Class A common stock"), and our Class B common stock, $0.00001 par value per share (the "Class B common stock" and, together with the Class A common stock, the "common stock"), as of the close of business on April 10, 2024

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing